Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription

Articles published in Virology

Retrieve available abstracts of 24 articles:
HTML format

Single Articles

    September 2022
  1. HANSEN T, Baris J, Zhao M, Sutton RE, et al
    Cell-based and cell-free firefly luciferase complementation assay to quantify Human Immunodeficiency Virus type 1 Rev-Rev interaction.
    Virology. 2022;576:30-41.
    PubMed     Abstract available

    July 2022
  2. RAI M, Rawat K, Muhammadi MK, Gaur R, et al
    Edelfosine reactivates latent HIV-1 reservoirs in myeloid cells through activation of NF-kappaB and AP1 pathway.
    Virology. 2022;574:57-64.
    PubMed     Abstract available

  3. ZHANG H, Deng T, Fang Q, Li S, et al
    Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses.
    Virology. 2022;574:1-8.
    PubMed     Abstract available

    June 2022
  4. BELIAKOVA-BETHELL N, Manousopoulou A, Deshmukh S, Mukim A, et al
    Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency.
    Virology. 2022;573:50-58.
    PubMed     Abstract available

    April 2022
  5. RAI M, Timilsina U, Gaur R
    Construction and characterization of a full-length, replication-competent and infectious enhanced green fluorescence protein-tagged HIV-1 subtype C molecular clone.
    Virology. 2022;571:34-38.
    PubMed     Abstract available

    January 2022
    Immune escape mutations selected by neutralizing antibodies in natural HIV-1 infection can alter coreceptor usage repertoire of the transmitted/founder virus.
    Virology. 2022;568:72-76.
    PubMed     Abstract available

  7. ROSENGARTEN JF, Schatz S, Wolf T, Barbe S, et al
    Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes.
    Virology. 2022;568:41-48.
    PubMed     Abstract available

    December 2021
  8. ZHANG Z, Zhang L, Shen Y
    Identification of immune features of HIV-infected patients with antiretroviral therapy through bioinformatics analysis.
    Virology. 2021;566:69-74.
    PubMed     Abstract available

    September 2021
  9. MACDONALD-OTTEVANGER MS, Boyd A, Prins M, van der Helm JJ, et al
    Differences in prevalence of hepatitis B virus infection and genotypes between ethnic populations in Suriname, South America.
    Virology. 2021;564:53-61.
    PubMed     Abstract available

    August 2021
  10. LIU H, Liu JB, Meng FZ, Xu XQ, et al
    CD4(+) T cell depletion does not affect the level of viremia in chronically SHIVSF162P3N-infected Chinese cynomolgus monkeys.
    Virology. 2021;560:76-85.
    PubMed     Abstract available

    July 2021
  11. OEYEN M, Meyen E, Noppen S, Claes S, et al
    Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
    Virology. 2021;562:74-86.
    PubMed     Abstract available

  12. KRUIZE Z, Cobos Jimenez V, Martinez FO, Di Vincenzo R, et al
    CD9 and ITGA3 are regulated during HIV-1 infection in macrophages to support viral replication.
    Virology. 2021;562:9-18.
    PubMed     Abstract available

  13. ALFADHLI A, Romanaggi C, Barklis RL, Merutka I, et al
    Capsid-specific nanobody effects on HIV-1 assembly and infectivity.
    Virology. 2021;562:19-28.
    PubMed     Abstract available

    June 2021
  14. DESROSIERS V, Barat C, Breton Y, Ouellet M, et al
    Thymidylate synthase is essential for efficient HIV-1 replication in macrophages.
    Virology. 2021;561:47-57.
    PubMed     Abstract available

    March 2021
  15. BELSHAN M, Holbrook A, George JW, Durant HE, et al
    Discovery of candidate HIV-1 latency biomarkers using an OMICs approach.
    Virology. 2021;558:86-95.
    PubMed     Abstract available

    February 2021
  16. ANGERSTEIN AO, Stoneham CA, Ramirez PW, Guatelli JC, et al
    Corrigendum to "Sensitivity to monoclonal antibody 447-52D and an open env trimer conformation correlate poorly with inhibition of HIV-1 infectivity by SERINC5" [Virology 2020 548, 73-81].
    Virology. 2021 Feb 10. pii: S0042-6822(21)00035.

  17. MONDAL S, Karmakar A, Mallick T, Begum NA, et al
    Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Virology. 2021;556:133-139.
    PubMed     Abstract available

  18. JAGUVA VASUDEVAN AA, Balakrishnan K, Franken A, Krikoni A, et al
    Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A.
    Virology. 2021;557:1-14.
    PubMed     Abstract available

    January 2021
  19. RABINOWITZ J, Sharifi HJ, Martin H, Marchese A, et al
    xCT/SLC7A11 antiporter function inhibits HIV-1 infection.
    Virology. 2021;556:149-160.
    PubMed     Abstract available

    December 2020
  20. OJWACH DBA, Madlala P, Gordon M, Ndung'u T, et al
    Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Virology. 2020;554:1-8.
    PubMed     Abstract available

  21. ZHANG Z, Perkovic M, Gu Q, Balakrishnan K, et al
    HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
    Virology. 2020;554:17-27.
    PubMed     Abstract available

    October 2020
  22. MCQUAID IK, Dorfman JR, Mall AS
    The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
    Virology. 2020;553:1-8.
    PubMed     Abstract available

    September 2020
  23. SHA SS, Dai Z, Wei QZ, Tao HX, et al
    Characteristics of HIV-1 env genes from Chinese chronically infected donors with highly broad cross-neutralizing activity.
    Virology. 2020;551:16-25.
    PubMed     Abstract available

  24. WIECZOREK L, Peachman K, Steers N, Schoen J, et al
    Selection and immune recognition of HIV-1 MPER mimotopes.
    Virology. 2020;550:99-108.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.